BioSpace News Archive

ANGANY announces the appointment of Christine Guillen, PharmD, as Chief Executive Officer.

Sun Pharmaceutical Industries, Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited, released results of a survey revealing defeatist attitudes about treatment among people with mild-to-moderate acne, despite feelings of self-consciousness.

Baxter International Inc., a global medtech leader, reported results for the third quarter of 2023.

Bruker Corporation announced financial results for its third quarter and for the nine months ended September 30, 2023.

Seres Therapeutics, Inc., a leading microbiome therapeutics company, reported financial results for the third quarter ended September 30, 2023, including VOWST net sales of $7.6 million.

Prokarium announces that the U.S. Food and Drug Administration has granted the company’s Investigational New Drug application for their immunotherapy ZH9.

Verana Health® announce a partnership focused on providing the life sciences community with deeper and broader data to optimize and expedite clinical trials.

Kura Oncology, Inc. and Mirati Therapeutics, Inc. announced a clinical collaboration and supply agreement to evaluate the combination of KO-2806, a next-generation farnesyl transferase inhibitor, and adagrasib, a highly selective KRASG12C inhibitor, in patients with KRASG12C-mutated non-small cell lung cancer.

Cognition Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2023 and provided recent business updates.

DENTSPLY SIRONA Inc. announced that Mr. Brian Gladden has been appointed to its Board of Directors, effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s retirement on December 31, 2023.